New Genetic Culprit Suspected of Pancreatic Cancer Onset
New research points to the inactivation of a previously unidentified gene as a likely culprit in the development of pancreatic cancer.
Read MorePosted by Andy Lundin | Dec 1, 2022 | Pancreatic |
New research points to the inactivation of a previously unidentified gene as a likely culprit in the development of pancreatic cancer.
Read MorePosted by Andy Lundin | Jun 28, 2022 | Pancreatic |
Pancreatic ductal adenocarcinoma affects more than 90% of patients with pancreatic cancer and has an average 5-year survival rate under 10%.
Read MorePosted by Andy Lundin | Mar 10, 2022 | Pancreatic |
Researchers have found a molecular signature in stool samples that could predict whether patients are at high risk of pancreatic cancer.
Read MorePosted by Chris Wolski | Jun 29, 2021 | Pancreatic |
Researchers from Queen Mary University of London have identified a protein that could be used to aid in the diagnosis of pancreatic cancer.
Read MorePosted by Chris Wolski | Jun 11, 2021 | Pancreatic |
The AI-based tool for predicting genomic subtypes of PDAC can be used in clinical practice worldwide for patient stratification.
Read More